These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 2566048

  • 1. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease.
    Masuda K, Nakajima A, Urayama A, Nakae K, Kogure M, Inaba G.
    Lancet; 1989 May 20; 1(8647):1093-6. PubMed ID: 2566048
    [Abstract] [Full Text] [Related]

  • 2. Cyclosporin A treatment of Behçet's disease: a long-term study.
    Díaz-Llopis M, Cervera M, Menezo JL.
    Curr Eye Res; 1990 May 20; 9 Suppl():17-23. PubMed ID: 2384009
    [Abstract] [Full Text] [Related]

  • 3. Short term cyclosporin A treatment of Behçet's disease.
    Müftüoğlu AU, Pazarli H, Yurdakul S, Yazici H, Ulkü BY, Tüzün Y, Serdaroğlu S, Altuğ E, Bahçecioğlu H, Güngen G.
    Br J Ophthalmol; 1987 May 20; 71(5):387-90. PubMed ID: 3580358
    [Abstract] [Full Text] [Related]

  • 4. [A case of Behçet's disease associated with neuromyopathy induced by combination therapy with colchicine and cyclosporin].
    Fujii Y, Arimura Y, Takahashi N, Toki T, Marumo T, Yoshihara K, Nakabayashi K, Yamada A.
    Ryumachi; 2003 Feb 20; 43(1):44-50. PubMed ID: 12692989
    [Abstract] [Full Text] [Related]

  • 5. A double-blind trial of colchicine in Behçet's syndrome.
    Yurdakul S, Mat C, Tüzün Y, Ozyazgan Y, Hamuryudan V, Uysal O, Senocak M, Yazici H.
    Arthritis Rheum; 2001 Nov 20; 44(11):2686-92. PubMed ID: 11710724
    [Abstract] [Full Text] [Related]

  • 6. Colchicine versus placebo in Behçet's disease: randomized, double-blind, controlled crossover trial.
    Davatchi F, Sadeghi Abdollahi B, Tehrani Banihashemi A, Shahram F, Nadji A, Shams H, Chams-Davatchi C.
    Mod Rheumatol; 2009 Nov 20; 19(5):542-9. PubMed ID: 19597921
    [Abstract] [Full Text] [Related]

  • 7. Behçet's disease.
    Mizushima Y.
    Curr Opin Rheumatol; 1991 Feb 20; 3(1):32-5. PubMed ID: 2043450
    [Abstract] [Full Text] [Related]

  • 8. Long-term effects of cyclophosphamide and colchicine treatment in Behçet's disease.
    Kazokoglu H, Saatçi O, Cuhadaroglu H, Eldem B.
    Ann Ophthalmol; 1991 Apr 20; 23(4):148-51. PubMed ID: 2064258
    [Abstract] [Full Text] [Related]

  • 9. Infliximab monotherapy versus infliximab and colchicine combination therapy in patients with Behçet's disease.
    Takeuchi M, Asukata Y, Kawagoe T, Ito N, Nishide T, Mizuki N.
    Ocul Immunol Inflamm; 2012 Jun 20; 20(3):193-7. PubMed ID: 22486264
    [Abstract] [Full Text] [Related]

  • 10. Cyclosporin A in the treatment of severe Behçet's uveitis.
    Binder AI, Graham EM, Sanders MD, Dinning W, James DG, Denman AM.
    Br J Rheumatol; 1987 Aug 20; 26(4):285-91. PubMed ID: 3300835
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of conventional therapy versus cyclosporine A in Behçet's syndrome.
    BenEzra D, Cohen E, Chajek T, Friedman G, Pizanti S, de Courten C, Harris W.
    Transplant Proc; 1988 Jun 20; 20(3 Suppl 4):136-43. PubMed ID: 3381269
    [Abstract] [Full Text] [Related]

  • 12. [Cyclosporin A treatment of Behçet's disease].
    Büsch R, Ruzicka T, Donhauser G.
    Hautarzt; 1990 Apr 20; 41(4):229-31. PubMed ID: 2358347
    [Abstract] [Full Text] [Related]

  • 13. [Low dose cyclosporin treatment for ocular lesions of Behçet's disease].
    Kotake S, Ichiishi A, Kosaka S, Yoshikawa K, Minagawa R, Matsuda H.
    Nippon Ganka Gakkai Zasshi; 1992 Oct 20; 96(10):1290-4. PubMed ID: 1442355
    [Abstract] [Full Text] [Related]

  • 14. Visual prognosis in patients with Behçet's disease receiving colchicine, systemic corticosteroid or cyclosporin.
    Hayasaka S, Kawamoto K, Noda S, Kodama T.
    Ophthalmologica; 1994 Oct 20; 208(4):210-3. PubMed ID: 7970549
    [Abstract] [Full Text] [Related]

  • 15. A double blind study of colchicine in Behçet's disease.
    Aktulga E, Altaç M, Müftüoglu A, Ozyazgan Y, Pazarli H, Tüzün Y, Yalçin B, Yazici H, Yurdakul S.
    Haematologica; 1980 Jun 20; 65(3):399-402. PubMed ID: 6778795
    [No Abstract] [Full Text] [Related]

  • 16. Low dose cyclosporin A versus pulsed cyclophosphamide in Behçet's syndrome: a single masked trial.
    Ozyazgan Y, Yurdakul S, Yazici H, Tüzün B, Işçimen A, Tüzün Y, Aktunç T, Pazarli H, Hamuryudan V, Müftüoğlu A.
    Br J Ophthalmol; 1992 Apr 20; 76(4):241-3. PubMed ID: 1390495
    [Abstract] [Full Text] [Related]

  • 17. Cyclosporine in Behçet's disease resistant to conventional therapy.
    Caspers-Velu LE, Decaux G, Libert J.
    Ann Ophthalmol; 1989 Mar 20; 21(3):111-6, 118. PubMed ID: 2735696
    [Abstract] [Full Text] [Related]

  • 18. Colchicine in the treatment of the cutaneous manifestations of Behçet's disease.
    Miyachi Y, Taniguchi S, Ozaki M, Horio T.
    Br J Dermatol; 1981 Jan 20; 104(1):67-9. PubMed ID: 7459271
    [Abstract] [Full Text] [Related]

  • 19. Interferon alfa-2b, colchicine, and benzathine penicillin versus colchicine and benzathine penicillin in Behçet's disease: a randomised trial.
    Demiroglu H, Ozcebe OI, Barista I, Dündar S, Eldem B.
    Lancet; 2000 Feb 19; 355(9204):605-9. PubMed ID: 10696980
    [Abstract] [Full Text] [Related]

  • 20. Management of necrotizing vasculitis with colchicine. Improvement in patients with cutaneous lesions and Behcet's syndrome.
    Hazen PG, Michel B.
    Arch Dermatol; 1979 Nov 19; 115(11):1303-6. PubMed ID: 507883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.